Navigation Links
Pharmacyclics Reports Financial Results and Recent Developments for Fiscal Year and Fourth Quarter 2011 - Conference Call Set for Today at 4:30 PM EDT
Date:9/12/2011

009-2019 from approximately $4.1 billion in 2009 to approximately $8.4 billion in 2019, as forecasted by Decision Resources, Inc. in the Non-Hodgkin's Lymphoma Onkos Study, April 2011.

Use of Non-GAAP Financial MeasuresThis press release contains non-GAAP financial measures, including operating and other expenses adjusted to exclude certain non-cash and non-recurring expenses. These measures are not in accordance with, or an alternative to generally accepted accounting principles, or GAAP, and may be different from non-GAAP financial measures used by other companies. The items included in GAAP presentations but excluded for purposes of determining non-GAAP financial measures that we present are: non-cash interest expense associated with the loan from an affiliate of Robert W. Duggan, pro-rata revenue related to prior services performed under the Servier Collaboration, employee related non-cash expenses, the withholding tax related to the Servier transaction, and the net amount of the therapeutic discovery project tax grant. We believe the presentation of non-GAAP financial measures provides useful information to management and investors regarding various financial and business trends relating to our financial condition and results of operations. When GAAP financial measures are viewed in conjunction with non-GAAP financial measures, investors are provided with a more meaningful understanding of our ongoing operating performance. In addition, these non-GAAP financial measures are among those indicators we use as a basis for evaluating operational performance, allocating resources and planning and forecasting future periods. Non-GAAP financial measures are not intended to be considered in isolation or as a substitute for GAAP financial measures. To the extent this release contains historical non-GAAP financial measures, we have also provided corresponding GAAP financial measures for comparative purposes. Reconciliation between certain GAAP and non-GAAP measu
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Pharmacyclics Announces Date of Fiscal Year End 2011 Financial Results and Conference Call
2. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
3. Pharmacyclics Announces Oral Presentations and Clinical Update at Upcoming Medical Meetings
4. Pharmacyclics to Announce Third Quarter Fiscal 2011 Results and Host a Conference Call on May 4, 2011
5. Pharmacyclics to Announce Second Quarter Fiscal 2011 Results and Host a Conference Call on February 4, 2011
6. Pharmacyclics Reports Updated Clinical Results from its Phase IA Trial of its First in Human Btk-Inhibitor PCI-32765
7. Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765
8. Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
9. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
10. Pharmacyclics to Present at Bank of America Merrill Lynch Healthcare Conference and MDB Bright Lights Conference
11. Pharmacyclics to Present at the RBC Capital Markets Healthcare Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015 As of February, ... incontinence devices for women. "Shipping thousands ... gratifying part is the hundreds of letters, emails ... lives have been positively impacted by our technology," ... InControl recently released Apex, an over-the-counter ...
(Date:3/27/2015)... DALLAS , March 27, 2015   ... global leader in biosimilars and the world,s leading ... two studies that support an evaluation of biosimilarity ... U.S. Food and Drug Administration (FDA) conditionally approved ... Amgen,s EPOGEN™ (epoetin alfa). These study data were ...
(Date:3/27/2015)... NEW BRUNSWICK, N.J. , March 27, 2015  Johnson ... Meeting of Shareholders at 10 a.m. (Eastern Time) on Thursday, ... New Brunswick, N.J. Investors and other ... meeting by visiting the Company,s website at www.jnj.com ... of presentations from the meeting will be made available a ...
Breaking Medicine Technology:InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3
... , MINNETONKA, Minn., Dec. 1 ... company specializing in clinical study management systems, today ... technology solution, has been certified by the Clinical ... the Operational Data Model (ODM) standard. This ...
... , CAMBRIDGE, Mass. and TOKYO, Dec. 1 Galenea ... further extension of their research and development collaboration through ... to seven years and brings the total committed funding ... working together since January 2005 with the goal of ...
Cached Medicine Technology:MedNet Solutions' ENLIGHTEN Receives CDISC ODM Certification 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3
(Date:3/27/2015)... Ticket Down is a reputable source of authentic ... Omaha, Nebraska on Friday, May 8th and Saturday, May 9th. ... be added in Omaha as Garth has done in other ... Brooks World Tour is continuing its run throughout the United ... and Trisha Yearwood will bring their act to Omaha, NE ...
(Date:3/27/2015)... March 27, 2015 On March ... with former Detroit Lions wide receiver Herman Moore, ... educational presentation on substance abuse, treatment options and ... who attended were pastors, ministers and bishops from ... other distinguished guests. , “Our ‘Fighting Addiction Together’ ...
(Date:3/27/2015)... USA (PRWEB) March 27, 2015 According ... rates of newborns born with Neonatal Abstinence Syndrome (NAS) ... NAS will undergo the painful withdrawal process for a ... body tremors, excessive crying, diarrhea, and vomiting. The condition ... undergoing drug and alcohol addiction treatment (and employing medically ...
(Date:3/27/2015)... GrassrootsHealth, an international nonprofit public health ... NOW! vitamin D demonstration project April 7 in the ... (MUSC), and will soon follow with a second phase ... to a minimum of 500 pregnant women at 17 ... service areas. The project will include patient and health ...
(Date:3/27/2015)... Operatic contenders and their avid audience ... 17th. The universally acclaimed baritone Sherrill Milnes will be ... Idol at The Merion in Evanston. The event is ... aspiring opera singers from around the country. “This is ... finest young talent in the country,” said Margaret Gergen, ...
Breaking Medicine News(10 mins):Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 2Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 3Health News:LiveToBeSober.org Hosts Conference on Substance Abuse Treatment and Recovery at Ford Field 2Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4Health News:Opera Idol Competition At The Merion In Evanston 2
... in 14 of Indonesia's 33 provinces has killed at least ... health officials said Tuesday//. ,But this month's figure ... when over 18,900 people were infected and the disease claimed ... ,The ministry had taken several measures to reduce the ...
... from Amgen Inc disclosed a rise in number of deaths ... that such drugs should be prescribed in restricted conditions only. ... on the natural protein called erythropoietin (EPO) which augments the ... is the major product of Amgen Inc and has also ...
... the government to bring about new and effective campaigns against ... be main reason for this sudden surge in AIDS cases ... there is a phenomenal 41% increase of HIV cases which ... spend $10 million for campaigns which would address these issues ...
... the extent of neurological ailments in the land of dreams//. ... Deborah Hirtz, and colleagues from the National Institute of Neurological ... treated neurological diseases in the country. , ... years and indexed the diseases according to various factors including ...
... sudden changes in your diet any more because of any ... health sciences, can help you have your own personalised diet ... ,Health expert Dr. Sam Rehnborg, the president of Nutrilite Health ... through the depression of making a sudden change in diet ...
... barely one month in Malaysia this year, a senior health ... said five more dengue fever deaths were reported in Selangor ... total death toll to 13 nationwide. ,In the ... of which 403 have been confirmed as dengue fever. ...
Cached Medicine News:
... safe care environment by automatically bar code printing ... level. The automated process and reliable bar codes ... of all items, including vials, ampules, syringes, IV ... saves valuable time for pharmacy staff and helps ...
wBloodCare™ provides functionality at the bedside to ensure that the correct patient receives the correct blood product....
Specimen-ID™, a Positive Specimen Identification System, assures the permanent link at the bedside between patient and laboratory specimen to prevent sample identification errors....
wCareMed™ utilizes barcode scanning technology to support medication administration. It is a simple to use point of care application that provides access to patient information on a lightweight,...
Medicine Products: